Papers
1
Total Citations
1
H-Index
1
About
Jisun Lee is a rising figure in gynecologic oncology, with a focused research interest in fertility-sparing treatments for early-stage cervical cancer. Her most cited work, a 2022 case report, addresses a critical clinical challenge: managing FIGO 2018 stage IB2 cervical cancer in women who wish to preserve fertility. Lee’s contribution lies in demonstrating the feasibility of neoadjuvant chemotherapy with a quick cisplatin-VP16 regimen, followed by robotic radical trachelectomy—a minimally invasive, fertility-preserving alternative to the standard radical hysterectomy. This approach offers a tailored strategy for patients with tumors between 2 and 4 cm, expanding options for delayed childbearing. While her citation count (1) reflects the early stage of her career, the work’s clinical relevance is underscored by its publication in a peer-reviewed journal, addressing a growing demand for personalized oncologic care. Lee’s research bridges surgical innovation and patient-centered outcomes, positioning her as a promising contributor to reproductive oncology. Her ongoing work is likely to influence guidelines for fertility preservation in cervical cancer management, making her a researcher to watch in this evolving field.
Research Focus
Key Achievements
Top Papers
- 1